Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for treatment of non-alcoholic steatohepatitis (NASH)
IRCT20231002059591N2Phase 3Completed
- Sponsor
- Galenos Arznei
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in metabolic dysfunction-associated steatohepatitis (MASH), sponsored by Galenos Arznei. Started Apr 2025; status: completed.
02
Drugs
melatonin
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on IRCT20231002059591N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231002059591N2.